Not enough data
Ryner Lai's articles primarily focus on scientific and healthcare topics, particularly medical research, clinical trials, disease treatment, drug therapies, and case reports. The coverage attributes indicate a heavy reliance on data citations.
Given the nature of Ryner's coverage, pitches should highlight access to unique or groundbreaking data relevant to medical research or clinical trials. Furthermore, experts who can provide insightful analysis based on concrete data are likely to resonate with Ryner's approach.
While there is no specific geographic focus mentioned for Ryner Lai’s coverage area in the provided information, it would be beneficial to offer insights that have global implications within the field of medical research and healthcare given the broad nature of their themes covered.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ryner Lai
A mixed-methods systematic review in BMC Medical Education finds that extra time can level exam performance for medical students with specific learning disabilities, but accommodations alone leave real gaps. The authors call for a comprehensive, flexible approach, and AI tools may have a role.
A propensity-matched analysis of more than 10,000 patients across seven solid tumors found that GLP-1 receptor agonists were associated with reduced metastatic progression, reaching statistical significance in four cancers. The authors call for randomized trials.
By: Ryner Lai
Olverembatinib combined with low-intensity chemotherapy achieved 63.0% complete remission (CR) with minimal residual disease [MRD] negativity in newly diagnosed patients with Philadelphia-chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), including among patients with genotypes typically associated with a poor prognosis, according to a poster presentation at the EHA 2026 Congress.
AI is taking on a growing role in mental healthcare, helping clinicians personalize treatment, monitor outcomes, and cut documentation time, according to a review in the Annual Review of Clinical Psychology.
AI can play a significant role in drug repurposing, identifying existing medicines that may work for new diseases, according to a review in the Annual Review of Medicine. Because these drugs are already approved, repurposing can be faster and cheaper than developing new ones.
A 20-year-old male patient presented with shortness of breath that worsened upon physical exercise, such as running. Combined with what felt like bone pain, he has been less physically active recently.
By: Ryner Lai
The use of ibrutinib in chronic lymphocytic leukemia (CLL ) can result in persistent benefits and a deepening response, but evidence on whether patients with undetectable minimal residual disease (uMRD) can safely discontinue treatment remains unclear. These findings were presented in a study published in Blood.
By: Ryner Lai
Bowen SG, Abdallah N, Pritchett JC, et al. Impact of outpatient CAR T-cell therapy administration on healthcare utilization in patients with
By: Ryner Lai
The addition of gabapentin to tramadol during concurrent chemoradiation (CCRT) drastically reduced the need for opioid escalation in patients with
By: Ryner Lai
Anselamimab therapy is associated with improved all-cause mortality (ACM) and reduced cardiovascular hospitalizations (CVHs) in patients with kappa immunoglobulin light chain (AL) amyloidosis, according to a study published in the Journal of Clinical Oncology.
